Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-75
SponsorDuan Chuanzhi

About this trial

APICES trial is an investigator-initiated, multicenter, multicenter, randomized, double-blind, placebo-controlled clinical trial that plans to enroll 396 patients with a 1-year follow-up, including a neurovascular imaging examination \[digital subtraction angiography (DSA), CT angiography (CTA) or magnetic resonance angiography (MRA)\] at 6 months after index treatment. It was designed in compliance with the Declaration of Helsinki and the International Conference on Harmonization Good Clinical Practice guidelines. The study was approved by the Ethics Committee of Zhujiang Hospital of South Medical University (2024-KY-032-02) and registered at ClinicalTrials.gov (NCT06308952). The participants will be recruited from twelve advanced stroke centers in China.

Eligibility criteria

Qualifiers

Aged 18 to 75 years old, male or non-pregnant female;

UIA diagnosed by CTA, MRA, or DSA;

Maximal aneurysmal diameter between 3 and 25mm;

Understands the nature of the procedure and provision of written informed consent;

Disqualifiers

Contraindications to atorvastatin treatment or known allergy to atorvastatin;

Pregnancy or lactation;

Presence of other vascular lesions (coronary artery disease, abdominal aortic aneurysm, intracranial atherosclerotic stenosis, arteriovenous malformation, dural arteriovenous fistula, Moyamoya disease, etc.);

Prolonged statin therapy (≥30 days) or prior indications for atorvastatin therapy according to the Chinese guidelines for lipid management (2023) 21;

Trial design

Treatments tested in this trial

  • Atorvastatin 20mg

Treatment groups

354 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Duan Chuanzhi

Lead sponsor

Zhujiang Hospital

Sponsor institution

Shenzhen Second People's Hospital

Collaborator

First Affiliated Hospital of Harbin Medical University

Collaborator

ZhuHai Hospital

Collaborator

First Hospital of Shijiazhuang City

Collaborator

Eighth Affiliated Hospital, Sun Yat-sen University

Collaborator

First Affiliated Hospital of Jinan University

Collaborator

Dongguan Kanghua Hospital

Collaborator

Beijing Tiantan Hospital

Collaborator

Guangdong 999 Brain Hospital

Collaborator

The First Affiliated Hospital of Zhengzhou University

Collaborator

First Affiliated Hospital of Chongqing Medical University

Collaborator

Dongguan People's Hospital

Collaborator

Xinqiao Hospital of Chongqing

Collaborator

Shanxi Cardiovascular Hospital

Collaborator

Peking Union Medical College Hospital

Collaborator

Tianjin Huanhu Hospital

Collaborator